Caladrius Biosciences Inc. (CLBS) dipped -6.23% or -0.19 to $2.86. It is nearly 21038 shares traded, which is 66.84% compare to the average total volume 31475. The market cap of CLBS is $29.66 million. The year to date change is -31.47%. The 52 week price range is from $2.84 to $11.65. Price of CLBS have changed 0.99% during last week. It have changed -15.75% over last month, -39.00% over last 3 months, -29.07% over last 6 months and -26.86% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 3.60. It is 25.87% above current price. The 200-day Moving Averages for CLBS is 4.63. It is 61.89% above current price. The 52-week High is 11.65. It is 307.34% from the current price. The 52-week Low is 2.84. It is -0.70% from current price.
There are some statistics of CLBS. It is has market cap $29.66 million. The share outstanding is 10.37 million. The average volume is 31475. The percent of top 15 Institution holding is 9.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is -25.35%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is -20.72%.